PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Pain 409,851 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.48
Renal Failure 73,993 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.51
Epilepsy 71,172 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.51
Prostate Cancer 71,064 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.51
Sepsis 64,798 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.52
Diarrhea 51,986 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.52
Seizure 44,685 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.53
Meningitis 41,685 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.53
Angiotensin Converting Enzyme 31,674 Target Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.53
Arrhythmia 29,330 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.54
EGF 27,487 Target Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.54
Platelet Aggregation 25,460 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.54
Dehydration 21,928 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.54
Endometriosis 16,342 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.55
Dyslipidemia 15,225 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.55
APOE 12,771 Target Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.56
Major Depressive Disorder 12,517 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.56
Platelet Activating Factor 9,915 Target Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.56
Hyperbilirubinemia 5,757 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.58
Hyperprolactinemia 4,112 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.59
Lanosterol 14 Alpha-Demethylase 101 Target Target 11-Beta-Hydroxylase 721 1 0.00 -0.99 0.01 0.68
CD4 112,219 Target Target 3-Phosphoinositide-Dependent Protein Kinase 1 230 1 0.00 -1.00 0.00 0.53
Diabetes 332,602 Disease Target 4-1BB Ligand 135 1 0.00 -1.00 0.01 0.52
Obesity 138,233 Disease Target 4-1BB Ligand 135 1 0.00 -1.00 0.01 0.53
Colon Cancer 30,064 Disease Target 4-1BB Ligand 135 1 0.00 -1.00 0.01 0.57
Cervical Cancer 28,286 Disease Target 4-1BB Ligand 135 1 0.00 -1.00 0.01 0.57
CEA 17,022 Target Target 4-1BB Ligand 135 1 0.00 -1.00 0.01 0.58
Conjunctivitis 8,825 Disease Target 4-1BB Ligand 135 1 0.00 -1.00 0.01 0.60
CD1A 2,739 Target Target 4-1BB Ligand 135 1 0.00 -1.00 0.01 0.63
BAFF 1,240 Target Target 4-1BB Ligand 135 1 0.00 -1.00 0.01 0.65
Carcinoma 433,099 Disease Drug 4-Mercaptobenzoic Acid 70 1 0.00 -0.99 0.01 0.52
Dehydration 21,928 Disease Drug 4-Mercaptobenzoic Acid 70 1 0.00 -0.99 0.01 0.59
Carcinoma 433,099 Disease Target 464.1 19 1 0.00 -0.97 0.05 0.54
Diabetes 332,602 Disease Target 464.1 19 1 0.00 -0.97 0.05 0.55
Renal Failure 73,993 Disease Target 464.1 19 1 0.00 -0.97 0.05 0.58
Prostate Cancer 71,064 Disease Target 464.1 19 1 0.00 -0.97 0.05 0.58
Acute Promyelocytic Leukemia 4,780 Disease Target 464.1 19 1 0.00 -0.97 0.05 0.65
Eotaxin 2,457 Target Target 464.1 19 1 0.00 -0.97 0.05 0.66
744.1 22 Target Target 464.1 19 1 0.05 -0.95 0.05 0.83
Cancer 1,053,491 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.51
Infection 766,637 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.51
Diabetes 332,602 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.53
Arthritis 128,324 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.55
Anxiety 113,510 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.55
CD4 112,219 Target Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.55
Rheumatoid Arthritis 78,952 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.56
Headache 50,687 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.57
Analgesia 44,857 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.57
Seizure 44,685 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.57
Calmodulin 25,240 Target Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.58
Epidermal Growth Factor Receptor 24,772 Target Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.58
ERK1 18,374 Target Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.59
Attention Deficit Hyperactivity Disorder 14,687 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.60
Phospholipase A2 13,400 Target Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.60
Adiponectin 11,994 Target Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.60
Glucocorticoid Receptor 10,306 Target Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.61
Eating Disorders 9,000 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.61
Obsessive Compulsive Disorder 8,508 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.61
Catechol O-Methyltransferase 2,877 Target Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.64
5-Hydroxytryptamine 2b Receptor 18 Target Target 5-Hydroxytryptamine 2a Receptor 67 1 0.03 -0.96 0.06 0.79
Obesity 138,233 Disease Target 5-Hydroxytryptamine 6 Receptor 12 1 0.00 -0.96 0.08 0.57
APOE 12,771 Target Target 5-Hydroxytryptamine 6 Receptor 12 1 0.00 -0.96 0.08 0.63
Diabetes 332,602 Disease Target 744.1 22 1 0.00 -0.98 0.05 0.55
Analgesia 44,857 Disease Target 744.1 22 1 0.00 -0.98 0.05 0.59
Tuberculosis 146,217 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.51
Anxiety 113,510 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.52
CD4 112,219 Target Target A1AT 329 1 0.00 -1.00 0.00 0.52
Influenza 67,933 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.53
Diarrhea 51,986 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.54
Osteoarthritis 36,287 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.55
Colon Cancer 30,064 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.55
Non Small Cell Lung Cancer 28,563 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.55
Cervical Cancer 28,286 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.55
Epidermal Growth Factor Receptor 24,772 Target Target A1AT 329 1 0.00 -1.00 0.00 0.56
Multiple Myeloma 24,594 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.56
ERK1 18,374 Target Target A1AT 329 1 0.00 -1.00 0.00 0.56
BNP 6,842 Target Target A1AT 329 1 0.00 -1.00 0.00 0.59
Fibromyalgia 6,837 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.59
Kidney Diseases 4,651 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.60
C5a 4,164 Target Target A1AT 329 1 0.00 -1.00 0.00 0.60
Ns3 3,189 Target Target A1AT 329 1 0.00 -1.00 0.00 0.61
CD22 1,591 Target Target A1AT 329 1 0.00 -1.00 0.00 0.63
ANGPTL4 289 Target Target A1AT 329 1 0.00 -1.00 0.00 0.69
AMBP 160 Target Target A1AT 329 1 0.00 -1.00 0.01 0.70
AACT 109 Target Target A1AT 329 1 0.01 -0.99 0.01 0.70
Alpha (Prolastin)- FDA 13 Drug Target A1AT 329 1 0.02 -0.96 0.08 0.73
CD4 112,219 Target Target A1M 59 1 0.00 -0.99 0.02 0.55
Infection 766,637 Disease Target AACT 109 1 0.00 -1.00 0.01 0.50
Diabetes 332,602 Disease Target AACT 109 1 0.00 -1.00 0.01 0.52
Tuberculosis 146,217 Disease Target AACT 109 1 0.00 -1.00 0.01 0.54
Anxiety 113,510 Disease Target AACT 109 1 0.00 -1.00 0.01 0.54
CD4 112,219 Target Target AACT 109 1 0.00 -1.00 0.01 0.54
Lung Cancer 91,416 Disease Target AACT 109 1 0.00 -1.00 0.01 0.55
Prostate Cancer 71,064 Disease Target AACT 109 1 0.00 -1.00 0.01 0.55
Osteoarthritis 36,287 Disease Target AACT 109 1 0.00 -1.00 0.01 0.57
Hearing Loss 30,622 Disease Target AACT 109 1 0.00 -1.00 0.01 0.57
Colon Cancer 30,064 Disease Target AACT 109 1 0.00 -1.00 0.01 0.57
Chronic Obstructive Pulmonary Disease 27,780 Disease Target AACT 109 1 0.00 -1.00 0.01 0.57
Platelet Aggregation 25,460 Disease Target AACT 109 1 0.00 -1.00 0.01 0.58
Bronchitis 18,336 Disease Target AACT 109 1 0.00 -1.00 0.01 0.58